A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY)
In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a diffe...
Saved in:
Published in | Current controlled trials in cardiovascular medicine Vol. 24; no. 1; pp. 527 - 14 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
13.08.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers.
The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h.
The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.
ClinicalTrials.gov NCT05513508. Registered on August 24, 2022. |
---|---|
AbstractList | BackgroundIn the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers.MethodsThe ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h.DiscussionThe development of pressure ulcers is a common side effect of NIV that negatively affects the patients’ comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.Trial registrationClinicalTrials.gov NCT05513508. Registered on August 24, 2022. In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. ClinicalTrials.gov NCT05513508. Registered on August 24, 2022. In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. Abstract Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. Methods The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. Discussion The development of pressure ulcers is a common side effect of NIV that negatively affects the patients’ comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. Trial registration ClinicalTrials.gov NCT05513508. Registered on August 24, 2022. Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers. Methods The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h. Discussion The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients. Trial registration ClinicalTrials.gov NCT05513508. Registered on August 24, 2022. Keywords: Noninvasive ventilation, Hypercapnic acute respiratory failure, Pressure ulcers, Rotational use of interfaces In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers.BACKGROUNDIn the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure. Pressure ulcers are a frequently observed NIV-related adverse effect, directly related to interface type and exposure time. Switching to a different interface has been proposed as a solution to improve patient comfort. However, large studies investigating the benefit of this strategy are not available. Thus, the aim of the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) is to investigate whether a protocolized rotational use of interfaces during NIV is effective in reducing the incidence of pressure ulcers.The ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h.METHODSThe ROTA-USE STUDY is a pragmatic, parallel arm, open-label, multicenter, spontaneous, non-profit, randomized controlled trial requiring non-significant risk medical devices, with the aim to determine whether a rotational strategy of NIV interfaces is associated with a lower incidence of pressure ulcers compared to the standard of care. In the intervention group, NIV mask will be randomly chosen and rotated every 6 h. In the control group, mask will be chosen according to the standard of care of the participating centers and changed in case of discomfort or in the presence of new pressure sores. In both groups, the skin underneath the mask will be inspected every 12 h for any possible damage by blinded assessors. The primary outcome is the proportion of patients developing new pressure sores at 36 h from randomization. The secondary outcomes are (i) onset of pressure sores measured at different time points, i.e., 12, 24, 36, 48, 60, 72, 84, and 96 h; (ii) number and stage of pressure sores and comfort measured at 12, 24, 36, 48, 60, 72, 84, and 96 h; and (iii) the economic impact of the protocolized rotational use of interfaces. A sample size of 239 subjects per group (intervention and control) is estimated to detect a 10% absolute difference in the proportion of patients developing pressure sores at 36 h.The development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.DISCUSSIONThe development of pressure ulcers is a common side effect of NIV that negatively affects the patients' comfort and tolerance, often leading to NIV failure and adverse outcomes. The ROTA-USE STUDY will determine whether a protocolized rotational approach can reduce the incidence, number, and severity of pressure ulcers in NIV-treated patients.ClinicalTrials.gov NCT05513508. Registered on August 24, 2022.TRIAL REGISTRATIONClinicalTrials.gov NCT05513508. Registered on August 24, 2022. |
ArticleNumber | 527 |
Audience | Academic |
Author | Scolletta, Sabino Cammarota, Gianmaria Dal Molin, Alberto Navalesi, Paolo Maggiore, Salvatore Maurizio Scala, Raffaele Longhini, Federico Crimi, Claudia Carlucci, Annalisa Rocca, Eduardo Nava, Stefano Scotti, Lorenza Cortegiani, Andrea De Vita, Nello Mattei, Alessio Misseri, Giovanni Vaschetto, Rosanna Gregoretti, Cesare |
Author_xml | – sequence: 1 givenname: Rosanna orcidid: 0000-0003-4625-4367 surname: Vaschetto fullname: Vaschetto, Rosanna – sequence: 2 givenname: Cesare surname: Gregoretti fullname: Gregoretti, Cesare – sequence: 3 givenname: Lorenza surname: Scotti fullname: Scotti, Lorenza – sequence: 4 givenname: Nello surname: De Vita fullname: De Vita, Nello – sequence: 5 givenname: Annalisa surname: Carlucci fullname: Carlucci, Annalisa – sequence: 6 givenname: Andrea surname: Cortegiani fullname: Cortegiani, Andrea – sequence: 7 givenname: Claudia surname: Crimi fullname: Crimi, Claudia – sequence: 8 givenname: Alessio surname: Mattei fullname: Mattei, Alessio – sequence: 9 givenname: Raffaele surname: Scala fullname: Scala, Raffaele – sequence: 10 givenname: Eduardo surname: Rocca fullname: Rocca, Eduardo – sequence: 11 givenname: Federico surname: Longhini fullname: Longhini, Federico – sequence: 12 givenname: Gianmaria surname: Cammarota fullname: Cammarota, Gianmaria – sequence: 13 givenname: Giovanni surname: Misseri fullname: Misseri, Giovanni – sequence: 14 givenname: Alberto surname: Dal Molin fullname: Dal Molin, Alberto – sequence: 15 givenname: Sabino surname: Scolletta fullname: Scolletta, Sabino – sequence: 16 givenname: Stefano surname: Nava fullname: Nava, Stefano – sequence: 17 givenname: Salvatore Maurizio surname: Maggiore fullname: Maggiore, Salvatore Maurizio – sequence: 18 givenname: Paolo surname: Navalesi fullname: Navalesi, Paolo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37574558$$D View this record in MEDLINE/PubMed |
BookMark | eNp9U01v1DAQDaiIfsAf4IAscSlSU5LYsbNc0KoUqFSpEm0PnCyvPd51lY1T21lUfj2T3Ra6FUJRksnMe29m4pn9bKfzHWTZm7I4LsuGf4glLTjNiwpvUfMiL59ne6Vgdc6rst55ZO9m-zHeFAWjE8peZrtU1Biqm71nh1PSBzVfquT0EfE9dHmrZtAekeXQJpdr6BKEIxJUZ_zS_QJDtO9S8G07mq3rnFYtScHh03ckLYAEn1DOd-gZIhBviRtFrNIQySqSmFBMBTNGtAqAYdIjA1NFVAKVUPqnSwuCDbtupaJbAel9dGltBIhxQNoKCa5dpyLWB6L0kIAs7noIWvVYGEFk74JKPtwRq1yLrI_rEr9fXE03JebXl6dbJZLLq-vPP8jhCFkH19_vX2UvrGojvL5_H2TXX06vTr7l5xdfz06m57muOUu5qIGCMKxQTNVUUG0VZUUDglsLogQxqdSkmPDaUGpKY2k9E9xYwxUzBaD3IDvb6BqvbmQf3FKFO-mVk2uHD3OpAh5WC7KmM1ppYIJTxoDPZpjbKGGtMRQqA6j1aaPVD7MlmPEsg2q3RLcjnVvIuV_JsmAVo6xChcN7heBvB4hJLl3U0LaqAz9EWTV1IcpJ05QIffcEeuOHgH94RLGJqDhO3F_UXGEHrrMeE-tRVE4FL3gzKShH1PE_UHgZWDqcP7AO_VuEt487_dPiw6AjoNkAdPAxBrBSu82UorJrsWM57pTc7JTEnZLrnZJjY9UT6oP6f0i_ARl3KQY |
CitedBy_id | crossref_primary_10_3389_fmed_2024_1364475 crossref_primary_10_4187_respcare_11886 crossref_primary_10_1016_j_heliyon_2025_e42500 |
Cites_doi | 10.1159/000509762 10.12968/jowc.2017.26.3.128 10.1371/journal.pone.0211476 10.1056/NEJMoa1503326 10.1093/ageing/afh086 10.1007/s00134-002-1208-7 10.1111/j.1742-481X.2007.00337.x 10.1016/j.apnr.2014.05.005 10.1097/01.CCM.0000178176.51024.82 10.1164/rccm.201106-1094OC 10.1016/j.rmed.2008.08.001 10.4037/ajcc2015386 10.1097/00003246-200006000-00015 10.1183/09031936.00123509 10.1055/s-0034-1383863 10.7861/clinmedicine.8-5-517 10.1007/s42600-020-00114-3 10.4187/respcare.03593 10.1007/s00134-012-2652-7 10.1378/chest.10-1905 10.1164/ajrccm.163.2.9906116 10.1111/j.1532-5415.2009.02307.x 10.1136/thoraxjnl-2015-208209 10.1097/00003246-200203000-00019 10.1213/ane.0b013e3181a1f708 10.1183/13993003.02426-2016 10.1097/01.CCM.0000256725.73993.74 10.1007/s00134-018-5478-0 10.1503/cmaj.130974 10.1183/23120541.00541-2020 10.4187/respcare.02942 10.1186/s13054-021-03595-5 10.1186/cc13175 10.4187/respcare.09625 10.1007/s001340050763 10.1097/CCM.0b013e3181928706 |
ContentType | Journal Article |
Copyright | 2023. BioMed Central Ltd., part of Springer Nature. COPYRIGHT 2023 BioMed Central Ltd. The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. BioMed Central Ltd., part of Springer Nature 2023 |
Copyright_xml | – notice: 2023. BioMed Central Ltd., part of Springer Nature. – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: BioMed Central Ltd., part of Springer Nature 2023 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s13063-023-07560-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1745-6215 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_53b32ce476344e6bb5e3da7ffdd3e2de PMC10424342 A760689036 37574558 10_1186_s13063_023_07560_1 |
Genre | Multicenter Study Randomized Controlled Trial Pragmatic Clinical Trial Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- 0R~ 123 2-G 29Q 2WC 53G 5VS 6PF 7RV 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACUHS ADBBV ADRAZ ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHYZX AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OVT PGMZT PHGZM PHGZT PIMPY PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP WOQ WOW ~8M CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 5GY 7XB 8FK AHMBA AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI XSB 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c564t-75e3e7d40a4a5373cfa3408e76ffe71e792a90965d33d1df35b76dfd6a4d0e5d3 |
IEDL.DBID | M48 |
ISSN | 1745-6215 |
IngestDate | Wed Aug 27 01:31:38 EDT 2025 Thu Aug 21 18:40:43 EDT 2025 Fri Jul 11 00:30:40 EDT 2025 Sat Aug 23 12:27:55 EDT 2025 Tue Jun 17 22:22:38 EDT 2025 Tue Jun 10 21:22:05 EDT 2025 Sat Aug 02 01:41:21 EDT 2025 Tue Jul 01 04:01:17 EDT 2025 Thu Apr 24 23:12:25 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Noninvasive ventilation Pressure ulcers Hypercapnic acute respiratory failure Rotational use of interfaces |
Language | English |
License | 2023. BioMed Central Ltd., part of Springer Nature. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c564t-75e3e7d40a4a5373cfa3408e76ffe71e792a90965d33d1df35b76dfd6a4d0e5d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0003-4625-4367 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13063-023-07560-1 |
PMID | 37574558 |
PQID | 2849726455 |
PQPubID | 44365 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_53b32ce476344e6bb5e3da7ffdd3e2de pubmedcentral_primary_oai_pubmedcentral_nih_gov_10424342 proquest_miscellaneous_2850719881 proquest_journals_2849726455 gale_infotracmisc_A760689036 gale_infotracacademiconefile_A760689036 pubmed_primary_37574558 crossref_citationtrail_10_1186_s13063_023_07560_1 crossref_primary_10_1186_s13063_023_07560_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-08-13 |
PublicationDateYYYYMMDD | 2023-08-13 |
PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-13 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Current controlled trials in cardiovascular medicine |
PublicationTitleAlternate | Trials |
PublicationYear | 2023 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | J-P Frat (7560_CR11) 2015; 372 C Roberts (7560_CR18) 2008; 8 KEA Burns (7560_CR2) 2014; 186 C Gorecki (7560_CR23) 2009; 57 R Vaschetto (7560_CR31) 2019; 45 S Nava (7560_CR32) 2009; 75 A Ozsancak (7560_CR38) 2011; 139 G Conti (7560_CR22) 1998; 24 AC Davidson (7560_CR1) 2016; 71 R Vaschetto (7560_CR3) 2021; 25 T Bashir (7560_CR30) 2019; 14 C Crimi (7560_CR26) 2010; 36 C Gregoretti (7560_CR34) 2002; 28 JR Curtis (7560_CR35) 2007; 35 G Bennett (7560_CR24) 2004; 33 F Moretto (7560_CR6) 2022; 67 R Vaschetto (7560_CR14) 2014; 18 DP Otero (7560_CR39) 2017; 26 D Chandra (7560_CR10) 2012; 185 K Tomii (7560_CR9) 2009; 103 G Schettino (7560_CR21) 2005; 33 L Brochard (7560_CR12) 2014; 35 S Mehta (7560_CR7) 2001; 163 B Rochwerg (7560_CR13) 2017; 50 BSM da Cunha-Martins (7560_CR37) 2021; 37 R Vaschetto (7560_CR5) 2021; 7 M Schallom (7560_CR17) 2015; 24 R Scala (7560_CR16) 2020; 99 C Girault (7560_CR27) 2009; 37 L Cabrini (7560_CR4) 2015; 60 P Navalesi (7560_CR15) 2000; 28 DR Hess (7560_CR8) 2005; 50 M Antonelli (7560_CR19) 2002; 30 WP Yamaguti (7560_CR20) 2014; 59 KM Newnam (7560_CR29) 2015; 28 P Drew (7560_CR25) 2007; 4 7560_CR36 R Vaschetto (7560_CR28) 2012; 38 F Racca (7560_CR33) 2009; 109 |
References_xml | – volume: 99 start-page: 800 year: 2020 ident: 7560_CR16 publication-title: Respiration doi: 10.1159/000509762 – volume: 26 start-page: 128 year: 2017 ident: 7560_CR39 publication-title: J Wound Care doi: 10.12968/jowc.2017.26.3.128 – volume: 14 start-page: e0211476 year: 2019 ident: 7560_CR30 publication-title: PLOS One doi: 10.1371/journal.pone.0211476 – volume: 372 start-page: 2185 year: 2015 ident: 7560_CR11 publication-title: N Engl J Med doi: 10.1056/NEJMoa1503326 – volume: 33 start-page: 230 year: 2004 ident: 7560_CR24 publication-title: Age Ageing doi: 10.1093/ageing/afh086 – volume: 28 start-page: 278 year: 2002 ident: 7560_CR34 publication-title: Intensive Care Med doi: 10.1007/s00134-002-1208-7 – volume: 4 start-page: 149 year: 2007 ident: 7560_CR25 publication-title: Int Wound J doi: 10.1111/j.1742-481X.2007.00337.x – volume: 28 start-page: 36 year: 2015 ident: 7560_CR29 publication-title: Appl Nurs Res doi: 10.1016/j.apnr.2014.05.005 – volume: 33 start-page: 1976 year: 2005 ident: 7560_CR21 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000178176.51024.82 – volume: 185 start-page: 152 year: 2012 ident: 7560_CR10 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201106-1094OC – volume: 103 start-page: 67 year: 2009 ident: 7560_CR9 publication-title: Respir Med Elsevier doi: 10.1016/j.rmed.2008.08.001 – volume: 24 start-page: 349 year: 2015 ident: 7560_CR17 publication-title: Am J Crit Care doi: 10.4037/ajcc2015386 – volume: 28 start-page: 1785 year: 2000 ident: 7560_CR15 publication-title: Crit Care Med doi: 10.1097/00003246-200006000-00015 – volume: 36 start-page: 362 year: 2010 ident: 7560_CR26 publication-title: Eur Respir J doi: 10.1183/09031936.00123509 – volume: 35 start-page: 492 year: 2014 ident: 7560_CR12 publication-title: Semin Respir Crit Care Med doi: 10.1055/s-0034-1383863 – volume: 8 start-page: 517 year: 2008 ident: 7560_CR18 publication-title: Clin Med (Lond) doi: 10.7861/clinmedicine.8-5-517 – volume: 37 start-page: 289 year: 2021 ident: 7560_CR37 publication-title: Res Biomed Eng doi: 10.1007/s42600-020-00114-3 – volume: 60 start-page: 586 year: 2015 ident: 7560_CR4 publication-title: Respiratory Care doi: 10.4187/respcare.03593 – volume: 38 start-page: 1599 year: 2012 ident: 7560_CR28 publication-title: Intensive Care Med doi: 10.1007/s00134-012-2652-7 – volume: 139 start-page: 1034 year: 2011 ident: 7560_CR38 publication-title: CHEST Elsevier doi: 10.1378/chest.10-1905 – volume: 163 start-page: 540 year: 2001 ident: 7560_CR7 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.163.2.9906116 – volume: 57 start-page: 1175 year: 2009 ident: 7560_CR23 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2009.02307.x – volume: 75 start-page: 31 year: 2009 ident: 7560_CR32 publication-title: Minerva Anestesiol – volume: 71 start-page: ii1 year: 2016 ident: 7560_CR1 publication-title: Thorax doi: 10.1136/thoraxjnl-2015-208209 – volume: 30 start-page: 602 year: 2002 ident: 7560_CR19 publication-title: Crit Care Med doi: 10.1097/00003246-200203000-00019 – volume: 109 start-page: 164 year: 2009 ident: 7560_CR33 publication-title: Anesth Analg doi: 10.1213/ane.0b013e3181a1f708 – volume: 50 start-page: 1602426 year: 2017 ident: 7560_CR13 publication-title: Eur Respir J doi: 10.1183/13993003.02426-2016 – volume: 35 start-page: 932 year: 2007 ident: 7560_CR35 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000256725.73993.74 – volume: 45 start-page: 62 year: 2019 ident: 7560_CR31 publication-title: Intensive Care Med doi: 10.1007/s00134-018-5478-0 – volume: 186 start-page: E112 year: 2014 ident: 7560_CR2 publication-title: CMAJ doi: 10.1503/cmaj.130974 – volume: 7 start-page: 00541 year: 2021 ident: 7560_CR5 publication-title: ERJ Open Res doi: 10.1183/23120541.00541-2020 – volume: 59 start-page: 1530 year: 2014 ident: 7560_CR20 publication-title: Respiratory Care Respiratory Care doi: 10.4187/respcare.02942 – volume: 50 start-page: 924 year: 2005 ident: 7560_CR8 publication-title: Respiratory Care – volume: 25 start-page: 189 year: 2021 ident: 7560_CR3 publication-title: Crit Care doi: 10.1186/s13054-021-03595-5 – volume: 18 start-page: R2 year: 2014 ident: 7560_CR14 publication-title: Crit Care doi: 10.1186/cc13175 – volume: 67 start-page: 1138 year: 2022 ident: 7560_CR6 publication-title: Respiratory Care doi: 10.4187/respcare.09625 – volume: 24 start-page: 1283 year: 1998 ident: 7560_CR22 publication-title: Intensive Care Med doi: 10.1007/s001340050763 – ident: 7560_CR36 – volume: 37 start-page: 124 year: 2009 ident: 7560_CR27 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3181928706 |
SSID | ssj0043934 ssj0017864 |
Score | 2.370527 |
Snippet | In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory failure.... Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory... BackgroundIn the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute respiratory... Abstract Background In the last decades, noninvasive ventilation (NIV) has been increasingly used to support patients with hypercapnic and hypoxemic acute... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 527 |
SubjectTerms | Adult Airway management Care and treatment Chronic obstructive pulmonary disease Clinical trials Complications and side effects Continuous positive airway pressure Critical care Extubation Hospital costs Humans Hypercapnic acute respiratory failure Intensive care Interfaces Internal medicine Intubation Medical care Medicine Noninvasive ventilation Noninvasive Ventilation - adverse effects Noninvasive Ventilation - methods Ostomy Patient outcomes Patients Positive-Pressure Respiration - adverse effects Positive-Pressure Respiration - methods Pressure Ulcer - epidemiology Pressure Ulcer - prevention & control Pressure ulcers Quality management Research design Respiratory failure Respiratory insufficiency Respiratory Insufficiency - therapy Rotational use of interfaces Standard of Care Study Protocol Treatment Outcome Ventilators |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEDZoD4gL4k1hQYOExCIabRM7scOtoF2tkAAJttJyspx4vFuptFXa7oFfz4yTlkZIcOFQKY3taJx8nof9eSzEKyPTzEmlE890NYVBJqXyWVLkaKoic8a7yLb4XJxN1MeL_GLvqC_mhLXpgdsXd5zLSmY1KhoHSmFRVTlK73QI3kvMPLL2JZu3DaZaHUxWVqrtFhlTHK9IU8f1SvppsvFJ2jNDMVv_nzp5zyj1CZN7Fuj0rrjTuY4wbkW-J27i_L649albHH9w42gMy8ZdxhysQ-BjsRL6xDgbQmQNJvxYbIZA1skvfkx_ooeOqD7jy26LJMRzPGAxB3INoVmsu9lC2KwQFgE4v0QTmMgF1yvYzkRwCZPIqBi6VK0riCR2ejTP9cKc532vHbPloWWK8UUM9qlZZF22tDwgNxpcvVkjXFGQ3NRuSYJB85sTAMFNmU3_Lor49cv5uBUxmXw76YkI7O9-hyOuEgvj_zcPxeT05PzDWdIdBJHUeaHWiaZvjtqrkVMul1rWgeA1MqiLEFCnqMvMlZzGxkvpUx9kXunCB1845UdIdx-JA-olPhFQIOEvlLlrlywJOVWhyY8JGsPI1DgQ6RYXtu6ypPNhHTMboyVT2BZLlrBkI5ZsOhBvd22WbY6Qv9Z-z3Db1eT83vEGod52qLf_Qv1AvGawWtZCJF7tus0U1EnO52XHmgJTU5J7MhCHvZqkPep-8RbuttNeK0suS6nJU87zgXi5K-aWzMib42LDdTiSKI2hDj1uR8euS1LnmhqbgTC9cdPrc79kPr2Kuc1TXoqXKnv6P97SM3E7i2PeJKk8FAfrZoPPyYdcVy-iuvgF-qJ0NQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwEDcwJMQL4pvCQIeExBCN1sSO7fCCCto0IQESrFJ5ipzY3iqVpqTtHvjruXPcbhHSHiqlOTs6J-f78s9nxt5onmaGC5VYgqsJ53lSCJslMne6kpnR1gS0xTd5MhFfpvk0JtxWEVa51YlBUdumphz5IarRQqH1zvOPyz8JnRpFq6vxCI1b7DaVLiNIl5ruAq5UaSm2G2W0PFyhvg6rlvhTaOmTtGeMQs3-_zXzFdPUh01esUPH99m96EDCuPviD9hNt3jI7nyNS-SPbhyMYdmas1CJdQh0OFaCH9rNhxCwgwk91rVDQBtlm9-zv85ChKvP6TJulIRwmgc0C0AHEdpmHXOGsFk5aDxQlYnWE5wLLlawzUcQhaBkSIZYsHUFAcqOj6aMLywo-3thCDMPHV6MLkLIj90C9rID5wE602DqzdrBOYbKbW2WyBi0l8gA8GZGmPoPgcUf30_HHYvJ5OdRj0Ugr_cXHFCTQAz_3z1mk-Oj088nSTwOIqlzKdaJyh13yoqRESbnitcehWyknZLeO5U6VWSmoGI2lnObWs_zSknrrTTCjhzefcL2cJTuGQPpUAp9kZtu4RJ9pkoq9Ga8cn6kazdg6VYuyjrWSqcjO-ZliJm0LDtZKlGWyiBLZTpg73d9ll2lkGtbfyJx27WkKt_hRtOelVFplDmveFY7gTZACCerCt-ANcp7a7nLLLL5loS1JF2E7NUmbqnAQVJVr3KsMDzVBTopA7bfa4k6pO6Tt-JeRh22Ki9n3IC93pGpJ-HyFq7ZUBuKJwqtcUBPu9mxGxJXucLOesB0b970xtynLGbnocJ5SgvyXGTPr-frBbubhdmsk5Tvs711u3Ev0UdcV6-CIvgHXtlqNw priority: 102 providerName: ProQuest |
Title | A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37574558 https://www.proquest.com/docview/2849726455 https://www.proquest.com/docview/2850719881 https://pubmed.ncbi.nlm.nih.gov/PMC10424342 https://doaj.org/article/53b32ce476344e6bb5e3da7ffdd3e2de |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9rC-KL-FlP6zGC4IONvWS_EkHkKq2l0CptD86nsMnutgfnXc3dFfWvd2aTOxss4sPlQvaDmTCzM7Pzyyxjr1IeJ4YLHVmCqwnneZQJm0RKurRQiUmtCWiLY3UwEIdDOVxjy-OOmhc4uzG0o_OkBtX47Y_vPz-gwr8PCp-qnRmuwyEbiT-NFjzCaGgDLZMmRT0Sq6wC2t46y6yFjBTauuVHNDfO0TJUoZ7_36v2NbPVhlRes1H799m9xrmEfi0ND9iamzxkd46a9PmjW5t9uKzMeajSug3EaIRC4MbbEHCFEU3rqm1A-2Wn30a_nIUGyj6m2-YjSggnfcB0Aug8QjWdN_uJsJg5mHqgChSVJ6gXXM1guVdBLQQzw2ZoirnOIMDccWraDYYJ7QxfGcLTQ40lo5uwHYDDAi6zBu4BOtpgysXcwQWG0VVpLpEwqP6gBsCbEeHt3wUSTz6f9WsSo8HpXotEII_462M22N87-3gQNSdDRKVUYh5p6bjTVvSMMJJrXnqUt17qtPLe6djpLDEZ1bWxnNvYei4Lray3ygjbc_j0CVtHptxTBsqhQPpMmjqHie5ToTQ6Nl4730tL12HxUgzysimbTqd3jPMQPqUqr0UnR9HJg-jkcYe9WY25rIuG_LP3LknXqicV_A4PptV53qwfueQFT0on0BwI4VRR4BuwRntvLXeJRTJfk2zmpChIXmmaryuQSSrwlfc1Rqpphv5Kh221euJyUrabl9KdL7UxRx8m0-g6S9lhL1fNNJIgehM3XVAfCi2yNEWGNmtlWLHEtUSdk2mHpS01afHcbpmMLkKx85hy81wkz_6bwefsbhL0OI1ivsXW59XCvUDPcV502W091F220e8fnh7i_-7e8ZeTbtiHweunYdwNC8ZvVq50qA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rb9MwEDdjk4AviDeFAYcEYohFa2IndpAQ6mDTxh6g0UnjU3Bje5s0mpK2Q_BH8Tdy5yTdIqR924dKafzQuT3fyz_fMfZC8TDSXMjAEFxNWMeDVJgoSGKrBkmkldEebbGbbOyLTwfxwRz729yFIVhlIxO9oDZFTjHyFRSjqUTtHcfvRz8DqhpFp6tNCY2KLbbs71_oso3fbX7E__dlFK2v9T9sBHVVgSCPEzEJZGy5lUZ0tdAxlzx3SGtXWZk4Z2VoZRrplHKiGM5NaByPBzIxziRamK7FtzjvVbYgOLoy82xhdW33y97s3EKqRDRXc1SyMkYN4c9J8SPRtgjClvrzVQL-1wXnlGEbqHlO863fYjdrkxV6FY_dZnN2eIdd26kP5e9eWerBqNSHPvfrMlA5rgBZy54sg0crBjStLZcBtaIpfhz_sQZqgPwJPdZXM8HXD4FiCGiSQllM6iglTMcWCgeU16J0BCCD0zE0ERBqIfAaNkOdInYMHjyPU1OMGYYUbz7VhNKHCqFGDz7IgMM82rOCAwKa76Dz6cTCETrnZa5HSBiUZ1gEcPqYUPxvPYl7n_u9isRg_-tai0QgO_sbLFEX3-i_v77H9i-FVe6zeVylfcggscj3Lo11dVSKVtogkWg_OWldV-W2w8KGL7K8zs5ORUJOMu-lqSSreClDXso8L2Vhh72ZjRlVuUku7L1K7DbrSXnF_YuiPMxqMZXFfMCj3ArUOkLYZDDAX8Bo6Zwx3EYGyXxFzJqR9EPycl1f4sBFUh6xrCfRIVYpmkUdttjqiVIrbzc37J7VUnOcne3xDns-a6aRhAQc2mJKfciDSZXCBT2odsdsSVzGEgerDlOtfdNac7tleHzkc6qHBAHgInp0MV3P2PWN_s52tr25u_WY3Yj8zlZByBfZ_KSc2idooU4GT2uxAOz7ZUuif8qbqSA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwEDdjSBMviG8KAw4JxBCN1sRO7CAhVNimjcFAsEnjKTixvU0aTUnbIfjT-Ou4c5JuEdLe9lApzdnWub0v2z_fMfZU8TDSXMjAEFxNWMeDVJgoSGKr8iTSymiPtthJNvfE-_14f4H9be_CEKyytYneUJuyoD3yVTSjqUTvHcerroFFfF7beDP-GVAFKTppbctp1CKybX__wuXb5PXWGv7Xz6JoY3333WbQVBgIijgR00DGlltpxEALHXPJC4d8D5SViXNWhlamkU4pP4rh3ITG8TiXiXEm0cIMLL7FcS-zK5LHIemY3J8v9kKpEtFe0lHJ6gR9hT8xxY_EKCMIO47Q1wv43yuccYtdyOYZH7hxnV1rglcY1tJ2gy3Y0U229LE5nr91aWUI40of-CywfaDCXAEKmT3ug8ctBjSsrfqA_tGUP47-WAMNVP6YHptLmuAriUA5AgxOoSqnzX4lzCYWSgeU4aJyBCWDkwm0eyFEIRgbkqFJFjsBD6PHoWm3GUa083yiCa8PNVaNHvx2A3bzuM8aGAgYyIMuZlMLh7hMrwo9RsagOkUlgNNHhOd_5Vn88ml3WLMY7H1d77AIFHF_gxVq4on--4vbbO9CBOUOW8RZ2nsMEosa4NJY14emGK_licRIyknrBqqwPRa2cpEVTZ52KhdynPn1mkqyWpYylKXMy1IW9tjLeZ9xnaXk3NZvSdzmLSnDuH9RVgdZY7CymOc8KqxA_yOETfIcfwGjpXPGcBsZZPM5CWtGdhDZK3RznQMnSRnFsqHEpbFKMUDqseVOS7RfRZfcinvW2M9JdqrtPfZkTqaehAkc2XJGbWgtkyqFE7pba8d8SlzGEjurHlMdvenMuUsZHR367OohgQG4iO6fz9djtoT2J_uwtbP9gF2NvGKrIOTLbHFazexDDFWn-SNvE4B9v2gj9A9tTavw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+pragmatic%2C+open-label%2C+multi-center%2C+randomized+controlled+clinical+trial+on+the+rotational+use+of+interfaces+vs+standard+of+care+in+patients+treated+with+noninvasive+positive+pressure+ventilation+for+acute+hypercapnic+respiratory+failure%3A+the+ROTAtional-USE+of+interface+STUDY&rft.jtitle=Trials&rft.au=Vaschetto%2C+Rosanna&rft.au=Gregoretti%2C+Cesare&rft.au=Scotti%2C+Lorenza&rft.au=De+Vita%2C+Nello&rft.date=2023-08-13&rft.pub=BioMed+Central+Ltd&rft.issn=1745-6215&rft.eissn=1745-6215&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs13063-023-07560-1&rft.externalDocID=A760689036 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon |